Thyroid hormone is reported to induce angiogenesis, which is mediated by the membrane receptor integrin avb3, but the precise signaling pathway is still not very clear. Recently, studies have shown that protein kinase D (PKD) regulates the recycling of integrin avb3, which is required for cell migration. Moreover, phosphorylated PKD stimulates histone deacetylase 5 (HDAC5) phosphorylation and nuclear export in endothelial cells. As a potent pro-angiogenic growth factor, basic fibroblast growth factor (bFGF (FGF2)) is a downstream target gene of HDAC5. Therefore, we examined the hypothesis that a novel signaling pathway through integrin avb3/PKD/HDAC5 might contribute to thyroxine (T 4 )-induced angiogenesis. We selected human umbilical vein endothelial cells (HUVECs) for treatment. Angiogenesis was assessed using wound-healing and tubulogenesis assays. Signaling molecules, including phosphorylated PKD and HDAC5, were measured by western blotting. bFGF mRNA was analyzed by real-time PCR. Our results showed that T 4 (100 nmol/l) stimulated the migration and formation of tube-like structures of HUVECs, whereas tetraiodothyroacetic acid (Tetrac, 100 nmol/l) inhibited T 4 -induced cell migration. Importantly, T 4 promoted the phosphorylation of PKD and HDAC5. These effects were inhibited respectively by Tetrac, PKC inhibitor (2.5 mmol/l) and PKD siRNA. Meanwhile, T 4 could promote the cytoplasmic accumulation of phosphorylated HDAC5 in HUVECs. In addition, bFGF mRNA expression in HUVECs significantly increased within 2 h of T 4 treatment, but was decreased by Tetrac. Our findings indicate that T 4 increases the expression of bFGF mRNA via the integrin avb3/PKD/HDAC5 signaling pathway, which plays an important role in angiogenesis.
angiopoietins, basic fibroblast growth factor (bFGF) and so on (di Blasio et al. 2010) .
Recently, effects of thyroid hormones, including L-thyroxine (T 4 ), and 3,5,3 0 -triiodo-L-thyronine (T 3 ), on angiogenesis have been observed in studies of the chick chorioallantoic membrane model , Mousa et al. 2006a and the human dermal microvascular endothelial cell microtubular model (Mousa et al. 2006a,b) . Bergh et al. (2005) identified integrin avb3 as a cell surface receptor for thyroid hormone (T 4 ) and as the initiation site for T 4 -induced angiogenesis. The extracellular domain of integrin avb3 includes an Arg-Gly-Asp (RGD) recognition site that is an important verification domain for the ligands of the protein (Plow et al. 2000) . The thyroid hormone receptor on integrin avb3 is located at or near the RGD recognition site. It is reported that T 4 is bound with greater affinity to integrin than T 3 . By binding to integrin avb3, the thyroid hormone signal is transduced by the MAPK (extracellular regulated kinase 1/2, ERK1/2) cascade , Bergh et al. 2005 . Several complex downstream events occur as a result of the activation of ERK1/2, including regulation of the activity of the plasma membrane Na C /H C antiporter (D'Arezzo et al. 2004) , an increase in activity of cell membrane Na C , K C -ATPase (sodium pump) (Lei et al. 2008) , secretion of some vascular growth factors including bFGF, consequent angiogenesis , etc. However, the precise signaling system of T 4 -induced angiogenesis has not been discovered yet. There is recycling of integrin avb3 in cells, which is required for cell migration (Ramsay et al. 2007 , Mai et al. 2011 ). di Blasio et al. (2010 found that protein kinase D1 (PKD1), a novel serine/threonine protein kinase, promotes integrin avb3 recycling and inhibits its endocytosis. PKD1 is also reported to be phosphorylated in endothelial cells in response to VEGF and serves as a histone deacetylase (HDAC) kinase (Vega et al. 2004a,b) . This signaling was confirmed by Ha et al. (2008a,b) to mediate VEGF-induced angiogenesis. They suggested that through a VEGF receptor 2-phospholipase Cg (PLCg)-protein kinase C (PKC)-PKD1dependent pathway, VEGF stimulates HDAC5 phosphorylation and nuclear export in endothelial cells, which induces gene expression and angiogenesis. Besides HDAC5, another class II a HDAC family member, HDAC7, which was also reported by Ha et al. (2008a,b) , is activated through the VEGF-PKD1-dependent pathway and accumulates in the cytoplasm of endothelial cells.
HDAC5-dependent regulation of gene expression is well known to control angiogenesis. By binding to the promoter of the bFGF (FGF2) and SLIT2 genes, HDAC5 represses the expression of these pro-angiogenic genes, whereas HDAC5 silencing promotes capillary sprouting of endothelial cells (Urbich et al. 2009 ). Accordingly, we propose that a new signaling pathway of integrin avb3/PKD/HDAC5 is involved in regulating bFGF expression, which further affects the angiogenesis induced by thyroid hormone.
Materials and methods
Materials L-T 4 and tetraiodothyroacetic acid (Tetrac) were purchased from Sigma-Aldrich. MAB to GAPDH, b-actin and PKC inhibitor (bisindolymaleimide I, HCl, Bis) were purchased from Santa Cruz Biotechnology, Inc. The Nuclear and Cytoplasmic Protein Extraction Kit was obtained from KeyGEN BioTECH (Nanjing, Jiangsu, China). Antiphosphorylated PKD, PKD, phosphorylated HDAC5 and HDAC5 were obtained from Cell Signaling Technology (Beverly, MA, USA). Matrigel was obtained from BD Biosciences (Franklin Lakes, NJ, USA). GenMute siRNA Transfection Reagent was purchased from SignaGen Laboratories (Ijamsville, MD, USA).
Cell culture and treatment
Human umbilical vein endothelial cells (HUVECs, ATCC, Manassas, VA, USA) were cultured in DMEM/F12 (Invitrogen) supplemented with 1000 U/l penicillin, 1 mg/ml streptomycin and 10% (v/v) fetal bovine serum (FBS) in an atmosphere of 5% CO 2 at 37 8C. For experimental purposes, 80% confluent HUVECs were preincubated for 24 h in a serum-free medium, the cells were treated for 15, 30, and 45 min with vehicle or T 4 (100 nmol/l). Tetrac (100 nmol/l) and Bis (2.5 mmol/l) were used to pretreat the cells for 30 min before adding T 4 .
Western blotting
Whole-cell lysates were prepared in RIPA buffer (Sigma-Aldrich) containing complete protease inhibitors (Roche Diagnostics Ltd), and protein concentration was determined using the Pierce BCA Protein Assay Kit (Thermo Fisher Scientific UK Ltd, Leicestershire, UK). Thirty micrograms of proteins were separated on an 8% SDS-polyacrylamide gel and transferred onto a nitrocellulose membrane for immunodetection. The membrane was then blocked in Tris-buffered saline with 0.25% Tween 20 (TBST) containing 5% (w/v) dried skimmed milk powder followed by overnight incubation at 4 8C with gentle shaking with primary antibody. The membrane was washed four times in TBST and incubated with the appropriate HRP-conjugated secondary antibody (Dako, Ely, UK) for 60 min at room temperature. The membrane was washed four times again in TBST. ECL plus reagents (GE Healthcare, Princeton, NJ, USA) were added to the membrane following the manufacturer's protocol. Any differences in protein phosphorylation due to variations in loading were routinely corrected by normalization to the levels of the appropriate total protein.
Nuclear and cytoplasmic protein extraction
HUVECs (5!10 6 -1!10 7 /ml) were collected and washed with cold PBS. The pellet was added with 200 ml cytoplasm lysis buffer (with 0.5 ml 10 mM DL-dithiothreitol, 1 ml 100 mM phenylmethylsulphonyl fluoride (PMSF), and 0.5 ml 1 mM protease inhibitors) and placed on ice for 15 min. Then the cells were centrifuged at 16 000 g for 5 min at 4 8C. The supernatant was carefully collected and cytoplasmic protein extract was obtained. One hundred microliters of nuclei lysis buffer (with 0.1 ml DL-dithiothreitol, 0.5 ml 100 mM PMSF, and 0.1 ml protease inhibitors) were added to resuspend centrifugal precipitate (nuclear), which was placed on ice for 40 min, then centrifuged at 16 000 g for 15 min at 4 8C. The supernatant was carefully removed and nuclear protein extract was obtained.
RNA interference
Cells were transfected with control siRNA (negative control, Shanghai GenePharma Co., Ltd, Shanghai, China) or siRNA specific to PKD (Shanghai GenePharma Co., Ltd) using GenMute transfection reagent (SignaGen Laboratories) according to the manufacturer's protocols (Table 1) . HUVECs were seeded at a concentration of 5!10 5 cells in six-well plates containing DMEM/F12 without FBS for 24 h. On the day of transfection, the siRNA-transfection reagent complex was prepared by diluting 25 nmol/l siRNA. This was followed by the addition of GenMute transfection reagent, gentle mixing and incubation for 20 min at room temperature. The siRNA-GenMute transfection reagent complexes were added dropwise to the cells. Cells were gently mixed and incubated for 6 h, following which T 4 and DMEM/F12 without FBS were added. Cells were incubated for 48 h before RNA or protein extraction.
Real-time PCR
Cells were harvested in TRIzol (Invitrogen) and total RNA was extracted according to the manufacturer's protocol. Primer pairs for bFGF were designed using the Primer3 software (http://bioinfo.ut.ee/primer3-0.4.0/). Basic Local Alignment Search Tool (BLAST) was used to ensure the specificity of the primer pair. RNA (2 mg) was subjected to RT-PCR using the Access RT-PCR system (Promega). Total RNA was reverse transcribed into cDNA at 70 8C for 5 min, then at 42 8C for 60 min. Second-strand synthesis and PCR amplification were performed for 40 cycles with denaturation at 95 8C for 30 s, annealing at 58 8C for 60 s, and extension at 70 8C for 120 s, with final extension at 68 8C for 7 min after completion of all cycles. All of the quantitative real-time RT-PCR measurements were performed using a CFX96 Touch Real-Time PCR Detection System (Bio-Rad Laboratories, Inc.) with SYBR Premix Ex Taq (Takara Bio, Inc., Shiga, Japan), according to the manufacturer's instructions. The primer pairs were as follows: bFGF, forward: 5 0 -TGG CTA TGA AGG AAG ATG GA-3 0 and reverse: 5 0 -ACT GCC CAG TTC GTT TCA GT-3 0 ; and UBC, forward: 5 0 -GTG GAT CGC TGT GAT CGT CAC-3 0 and reverse: 5 0 -TGT CAC TGG GCT CAA CCT CG-3 0 . UBC was used as the control amplicon. The results were measured by the formula: 2 KDDCt . KDDCtZK((target gene in sample CtKUBC gene in sample Ct)K(target gene in control CtKUBC gene in control Ct)).
Wound-healing assay
HUVECs were seeded in six-well plates with growth medium containing 10% FBS. The cells were allowed to grow to form a confluent monolayer. The wound-induced migration was triggered by scraping the cells with a plastic pipette tip, and the wound was imaged immediately. 
The cells were then treated with T 4 or Tetrac. The wound was imaged at different intervals as indicated using an inverted phase-contrast microscope. The wound gap was measured on the images and the distance of migration was calculated as wound gap at 0 hKwound gap at x h, where x is the time point of measurement, and the average woundhealing time was calculated based on at least nine determinations of the wound (Sharlow et al. 2008) .
Tubulogenesis assay
The effect of thyroid hormone on tubulogenesis was tested by determining the formation of capillary-like tubes in 96-well plates loaded with Matrigel. Matrigel was thawed at 4 8C overnight before use. A total of 440 ml of Matrigel were mixed with 2!10 4 HUVECs in a total volume of 220 ml. A 50 ml aliquot of the Matrigel cell mixture was then added to each well and incubated at 37 8C for 30 min to allow gel formation. This was followed by the addition of 250 ml culture medium and incubation at 37 8C for 48 h.
After washing, the cell medium was replaced with culture medium mixed with thyroid hormone (T 4 : 100 nmol/l), which was replaced every 24 h for 2 days. The tube-like structures inside the wells were fixed with 4% formaldehyde and photographed (Zhang et al. 2010) . The total length of the capillary-like network that was formed within the Matrigel was measured using Image J software (National Institutes of Health, Bethesda, MD, USA).
Statistical analysis
The data were summarized as meanGS.E.M. Unpaired Students' t-test was used for comparisons between two groups. For multiple comparisons, statistical analysis was performed by ANOVA. P values !0.05 were considered to be significant.
Results

T 4 promoted the migration and tubulogenesis of HUVECs
The effect of T 4 on cell migration was examined by woundhealing assay in HUVECs. Confluent HUVECs were wounded and then treated with T 4 or Tetrac. We found that the migration ability of HUVECs changed with time and was different in each group (Fig. 1 ). The T 4 (100 nmol/l) group showed a longer distance of migration than the control group, whereas the Tetrac (100 nmol/l)CT 4 group showed a shorter distance of migration than T 4 group at 8, 12, and 24 h (P!0.05), which indicated that T 4 was able to induce HUVEC migration, and that Tetrac significantly inhibited the effects of T 4 . The effect of Tetrac alone on cell migration did not result in a significant difference from the control group (PO0.05). In addition, we investigated the effects of T 4 on the capability of HUVECs to form capillarylike structures in Matrigel and quantified it by measuring the number and length of capillary-like structures. Our results showed that after 48 h of T 4 treatment, although the length of tube-like structures in the T 4 group was not significantly different from that in control group (PO0.05), the number of tube-like structures obviously increased in the T 4 group (P!0.05) (Fig. 2) . These results indicated that T 4 had a strong ability to induce capillary-like tube formation and migration of HUVECs.
The signaling pathway of angiogenesis induced by T 4 T 4 induced the phosphorylation of PKD To examine the potential role of PKD in the T 4 -stimulated signaling pathway, we first observed PKD phosphorylation in HUVECs in response to T 4 . HUVECs were stimulated with T 4 (100 nmol/l) at different times as indicated. As shown in Fig. 3A , T 4 rapidly induced PKD phosphorylation within 15 min (P!0.05). This higher activation was maintained until 45 min (P!0.05). To confirm the role of integrin avb3 in T 4 -induced angiogenic effects, we used Tetrac to inhibit the binding of T 4 to integrin avb3 in HUVECs. Our results showed that, to certain extent, T 4 increased the phosphorylation of PKD, which was inhibited by Tetrac in a dose-dependent way (Fig. 3B) . PKD, as a downstream target of the PLCg-PKC pathway, was reported to mediate the signal transduction and regulate many cellular functions. It is possible that PKC might be involved in the phosphorylation of PKD induced by T 4 . Our data showed that PKC inhibitor (Bis) also inhibited PKD phosphorylation induced by T 4 , and this inhibitory action diminished with time ( Fig. 3C ).
T 4 stimulated HDAC5 phosphorylation and cytoplasmic accumulation Figure 3D shows that the expression of phosphorylated HDAC5 in the T 4 group was nearly 1.5-fold higher than that in the control group (P!0.05). Compared with the T 4 group, different concentrations of Tetrac effectively inhibited T 4 -induced HDAC5 phosphorylation (P!0.05). However, we barely observed any significant difference in HDAC5 phosphorylation with different concentrations of TetracCT 4 (PO0.05, Fig. 3D ). In addition, nuclear export of HDAC5 depended on its phosphorylation, which further affected the downstream gene expression. To confirm the subcellular location of phosphorylated HDAC5 in T 4 -activated signaling events, we examined the cytoplasmic localization of T 4 -induced HDAC5 phosphorylation in HUVECs. Our results showed that there was cytoplasmic accumulation of phosphorylated HDAC5 after administration of T 4 for 15 min (1.39-fold when compared with the control group, P!0.05). While Bis and Tetrac inhibited T 4 -induced cytoplasmic accumulation of phosphorylated HDAC5 (Fig. 4) . Collectively, these results suggested that T 4 induced the cytoplasmic accumulation of phosphorylated HDAC5 in HUVECs by activating the integrin avb3/PKC pathway.
T 4 -induced phosphorylation of HDAC5 mediated by PKD To further define the role of PKD in T 4 -induced HDAC5 phosphorylation, we knocked down the endogenous PKD in HUVECs using siRNA specifically targeting human PKD. All three PKD siRNAs significantly inhibited the expression of PKD (PRKD1) mRNA and protein (Fig. 5A, B) . Particularly, PKD siRNA significantly repressed T 4 -induced HDAC5 phosphorylation (Fig. 5C ). Here, we confirmed an essential role of PKD in T 4 -induced HDAC5 phosphorylation in HUVECs. Effects of T 4 on tubulogenesis of HUVECs. HUVECs were mixed with Matrigel (total 50 ml) for 30 min at 37 8C in an atmosphere of 5% CO 2 to allow formation of the gel. This was followed by the addition of 250 ml HUVEC cell medium (5!10 3 cells per well) and incubation at 37 8C for 48 h. After washing with PBS, the cell medium was replaced with HUVECs medium mixed with thyroid hormone (T 4 : 100 nmol/l), which was replaced every 24 h for 48 h. The tube-like structures inside the wells were photographed. The total length and number of the capillary-like structures (indicated by arrows) that were formed within the Matrigel were measured. Compared with the control group, the number in the T 4 group was greater (*,P!0.05 compared with the control group), and the length of tube-like structures (PO0.05) was longer, but the difference was not statistically significant.
T 4 increased the expression of bFGF mRNA via the integrin avb3/PKD/HDAC5 signaling pathway
As a potent pro-angiogenic factor, bFGF is one of the numerous target genes regulated by HDAC5. To investigate whether the pro-angiogenic action of T 4 was related to induction of bFGF expression via the integrin avb3/PKD/ HDAC5 pathway, we examined the expression of bFGF with real-time PCR. HUVECs were treated with T 4 or Tetrac for 2-6 h. The results showed that an increase in bFGF expression was obvious after 2 h of T 4 treatment (2.637-fold when PKD and HDAC5 phosphorylation in HUVECs. (A) T 4 -stimulated PKD phosphorylation. HUVECs were starved without serum for 24 h and incubated with T 4 (100 nmol/l) for 15, 30, and 45 min. Cell lysates were prepared and subjected to western blotting using a specific antibody. GAPDH was used as a loading control. Quantification of bands was done by densitometric analysis. The results are representative of three independent experiments. *P!0.05 when compared with the control group. (B) Tetrac inhibited PKD phosphorylation induced by T 4 . HUVECs were starved without serum for 24 h, then Tetrac (10 K7 , 10 K6 , and 10 K5 mol/l) was added 30 min before T 4 (100 nmol/l, 30 min) addition. The results are representative of three independent experiments.*P!0.05 when compared with the control group. # P!0.05 when compared with the T 4 group. (C) PKC inhibitor (bisindolymaleimide I, Bis) inhibited PKD phosphorylation induced by T 4 . HUVECs were starved without serum for 24 h, and then they were pretreated with Bis (2.5 mmol/l) for 30 min and finally with T 4 (100 nmol/l) for 15, 30, and 45 min. The results were representative of three independent experiments. *P!0.05 when compared with the control group. # P!0.05 when compared with the T 4 group treated at the same time. (D) Effects of T 4 and Tetrac on phosphorylation of HDAC5. HUVECs were starved without serum for 24 h, and then they were pretreated with Tetrac (10 K7 , 10 K6 , and 10 K5 mol/l) for 30 min and finally with T 4 (100 nmol/l) for 30 min. The results were representative of three independent experiments.*P!0.05 when compared with the control group, # P!0.05 when compared with the T 4 group.
compared with the control group, P!0.05); whereas Tetrac effectively prevented T 4 -induced expression of bFGF mRNA during the 2 h time period (P!0.05) ( Table 2) . Expression of bFGF mRNA in HUVECs decreased gradually with time in all groups, and the difference between groups was not statistically significant at 6 h (PO0.05).
Discussion
In recent years, many studies have focused on investigating T 4 -induced angiogenesis. Schlenker et al. (2008) reported that hypothyroidism in rats induces a decrease in brain blood vessel density. Replacement with 3,5-diiothyroprionic acid and T 4 effectively prevented the effects of hypothyroidism on cardiac function and increased blood vessel density. Thyroid hormones also exhibit direct proangiogenic effects on brain endothelial cells, i.e. increasing brain endothelial cell expansion and formation of tube-like structures (Zhang et al. 2010) . One possible explanation for this is the ability of thyroid hormone to regulate the dynamics of cytoskeleton remodeling, a key structural component required for cells to migrate. This proangiogenic mechanism is confirmed by the findings of Farwell et al. (2006) , which indicate that the T 4 -dependent actin polymerization in developing neurons is necessary for migrating cells to recognize the laminin guidance molecule. Both T 4 and 3,3 0 ,5-triiodothyronine (rT 3 ) exert direct, positive control of the quantity of polymerized actin in cultured astrocytes without affecting gene expression.
In our study, T 4 was also discovered to be associated with angiogenesis in HUVECs. We found that T 4 promoted HUVEC migration and formation of tube-like structures. Meanwhile, Tetrac, a pure inhibitor of the binding of T 4 and T 3 to integrin avb3 (Bergh et al. 2005 ), prevented T 4 -induced cell expansion. Our results indicated that T 4 showed a strong ability to regulate HUVEC angiogenesis, which was initiated at the membrane receptor integrin avb3, and the use of Tetrac was appropriate for investigating the participation of the receptors in actions of thyroid hormone analogs. This result is consistent with previous research showing that integrin avb3 is required in thyroid-hormone-induced angiogenesis. Studies report that the extracellular domain of integrin avb3 includes an RGD recognition site, which is an important verification domain for the ligands of the protein. The thyroid hormone receptor domain is at or near the RGD recognition site on integrin avb3 (Bergh et al. 2005 , Cody et al. 2007 . By binding to integrin avb3, thyroid hormone activates several downstream signaling molecules to regulate signal transduction.
Integrin avb3 contains two thyroid hormone-binding sites, denoted as S 1 and S 2 , which translate the thyroid hormone signal differently (Davis et al. 2011) . Several studies have shown that the signaling pathway of angiogenesis induced by T 4 is mediated by S 2 , and ultimately activates the ERK1/2 pathway ). Interestingly, there is recycling of integrin avb3 in cells, i.e. from endosomal compartment to plasma membrane, which is required for cell migration (Pellinen & Ivaska 2006 , Shattil et al. 2010 . There are some signaling molecules involved in regulating this complicated cellular recycling. Among them, PKD1 can interact with integrin avb3 in endothelial cells and regulate its trafficking in two different ways: on the one hand, it promotes integrin avb3 recycling, and on the other hand, it inhibits integrin avb3 endocytosis (di Blasio et al. 2010). Wong & Jin (2005) also confirmed that PKD, as a downstream target, is involved in VEGF-induced MAPK signaling and proliferation of endothelial cells. This evidence indicates a potential signaling role of PKD, which is activated by T 4 binding to integrin avb3, involved in T 4 -induced angiogenesis. Thus, we evaluated the phosphorylation of PKD in our model and found that T 4 increased PKD phosphorylation in HUVECs, whereas Tetrac inhibited T 4 -induced PKD phosphorylation. However, the dose-dependent inhibitory effect of Tetrac Expression of phosphorylated HDAC5 in the cytoplasm. HUVECs were starved without serum for 24 h, and then they were pretreated with Tetrac (100 nmol/l) or Bis (2.5 mmol/l) for 30 min and finally with T 4 (100 nmol/l) for 30 min. Cytoplasmic protein was extracted, and phosphorylation of HDAC5 was observed in the cytoplasm. GAPDH was used as a loading control. The results are representative of three independent experiments. *P!0.05 when compared with the control group, # P!0.05 when compared with the T 4 group.
was observed only for a certain range of concentrations, which was possibly attributable to the lower potency of the thyromimetic activity of Tetrac within the cell (Moreno et al. 2008) . Our results confirmed that T 4 stimulated the phosphorylation of PKD by binding to integrin avb3. By stimulating PKD phosphorylation, T 4 might promote the recycling of integrin avb3, therefore generating a positive feedback, enhancing the effects of T 4 . Many studies report that the phosphorylation of PKD depends on the activation of PKC (Vega et al. 2004a,b) . To further clarify the role of PKC in T 4 -induced PKD phosphorylation, we pretreated HUVECs with PKC inhibitor. Our results showed that T 4 -stimulated PKD phosphorylation was reduced by PKC inhibitor. The data implied that the integrin avb3/PKC signaling pathway was involved in PKD activation induced by T 4 . In contrast to the previous studies, we first reported that through activation of the integrin avb3/PKC/PKD pathway, T 4 induced the phosphorylation of HDAC5. We used both Tetrac and PKC inhibitor to block the signaling pathway and discovered that HDAC5 phosphorylation stimulated by T 4 was reduced. We also designed PKD siRNA to inhibit PKD expression and found that cellular HDAC5 phosphorylation significantly decreased. Class II a HDAC family members, especially HDAC5 and HDAC7, Effects of PKD siRNA on phosphorylation of HDAC5 induced by T 4 . (A) Expression of PKD mRNA in HUVECs after transfection with PKD siRNA. HUVECs were starved without serum for 24 h. Transfection reagent with negative control siRNA (25 nmol/l) or one of the three PKD siRNAs (25 nmol/l) was added to cell culture medium for 6 h, then the transfection reagent was replaced with culture medium. HUVECs were cultured for another 24 h, and PKD and UBC cDNAs were isolated. The levels of PKD cDNA were corrected for variations in UBC cDNA. (B) Expression of PKD protein in HUVECs after transfection with PKD siRNA. HUVECs were transfected with a vehicle, negative siRNA (25 nmol/l) or PKD siRNA (25 nmol/l) for 6 h, and then the transfection reagent was removed. After culturing for 48 h, HUVECs were treated with T 4 (100 nmol/l) for 15 min. b-actin was used as a loading control. *P!0.05 when compared with the control group. # P!0.05 when compared with the T 4 group. (C) Phosphorylation of HDAC5 induced by T 4 was inhibited by PKD siRNA. After HUVECs were transfected with a negative siRNA (25 nmol/l, control) or PKD siRNA (25 nmol/l), culture was continued for 48 h, and then cells were exposed to T 4 (100 nmol/l) for 15 and 30 min. Representative immunoblot data are shown (nZ3). *P!0.05 when compared with the control group, # P!0.05 when compared with the T 4 group. 
